A Dual SIRT6/Classical HDAC Inhibitor with Integrated Antiproliferative, Antimigratory, and Pharmacokinetic Advantages Against Pancreatic Cancer
Year: 2026
Type: article
Source: Journal of Medicinal Chemistry
Institutions: Southern Medical University, Shanghai Jiao Tong University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Awards: G2030198899, G2174352892, G2824183592
OpenAlex ID: W7225879061
